BE881680A - Composition pharmaceutique a base d'acylcarnitine pour le traitement d'un metabolisme cerebral altere et methode utilisee a cet effet - Google Patents
Composition pharmaceutique a base d'acylcarnitine pour le traitement d'un metabolisme cerebral altere et methode utilisee a cet effetInfo
- Publication number
- BE881680A BE881680A BE0/199368A BE199368A BE881680A BE 881680 A BE881680 A BE 881680A BE 0/199368 A BE0/199368 A BE 0/199368A BE 199368 A BE199368 A BE 199368A BE 881680 A BE881680 A BE 881680A
- Authority
- BE
- Belgium
- Prior art keywords
- acylcarnitine
- treatment
- pharmaceutical composition
- method used
- composition based
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT7947976A IT1206954B (it) | 1979-02-12 | 1979-02-12 | Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche |
IT50795/79A IT1164062B (it) | 1979-11-09 | 1979-11-09 | Composizione farmaceutica comprendente una acil-carnitina per il trattamento del rallentato metabolismo cerebrale |
Publications (1)
Publication Number | Publication Date |
---|---|
BE881680A true BE881680A (fr) | 1980-05-30 |
Family
ID=26329263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/199368A BE881680A (fr) | 1979-02-12 | 1980-02-12 | Composition pharmaceutique a base d'acylcarnitine pour le traitement d'un metabolisme cerebral altere et methode utilisee a cet effet |
Country Status (8)
Country | Link |
---|---|
US (1) | US4346107A (fr) |
AU (1) | AU535518B2 (fr) |
BE (1) | BE881680A (fr) |
CH (1) | CH641673A5 (fr) |
DE (1) | DE3005208A1 (fr) |
FR (1) | FR2448348A1 (fr) |
GB (1) | GB2046593A (fr) |
NL (1) | NL8000768A (fr) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1198434B (it) * | 1981-01-06 | 1988-12-21 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina |
IT1142934B (it) * | 1981-11-06 | 1986-10-15 | Sigma Tau Ind Farmaceuti | Uso della carnitina e delle acilcarnitine inferiori nel trattamento terapeutico della patologia delle vene |
IT1157238B (it) * | 1982-10-29 | 1987-02-11 | Sigma Tau Ind Farmaceuti | Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile |
IT1150396B (it) * | 1982-12-09 | 1986-12-10 | Sigma Tau Ind Farmaceuti | Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari |
CH655005A5 (it) * | 1983-02-16 | 1986-03-27 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare. |
IT1181682B (it) * | 1985-06-11 | 1987-09-30 | Sigma Tau Ind Farmaceuti | Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto |
IT1184655B (it) * | 1985-10-14 | 1987-10-28 | Sigma Tau Ind Farmaceuti | Imiego di acetil l-carnitina nel trattamento terapeutico degli stati di shock |
IT1195852B (it) * | 1986-07-04 | 1988-10-27 | Sigma Tau Ind Farmaceuti | Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati |
IT1196564B (it) * | 1986-08-04 | 1988-11-16 | Sigma Tau Ind Farmaceuti | Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche |
SE8701662L (sv) * | 1987-04-22 | 1988-10-23 | Gelder Nico M Van | Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna |
IT1224842B (it) * | 1988-12-27 | 1990-10-24 | Sigma Tau Ind Farmaceuti | Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso |
IT1230141B (it) * | 1989-05-03 | 1991-10-14 | Fidia Spa | Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale. |
IT1244636B (it) * | 1991-01-04 | 1994-08-08 | Sigma Tau Ind Farmaceuti | Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento. |
IT1263004B (it) * | 1992-10-08 | 1996-07-23 | Sigma Tau Ind Farmaceuti | Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti. |
JP4598203B2 (ja) * | 1995-12-01 | 2010-12-15 | ビーティージー・インターナショナル・リミテッド | 脳機能改善剤 |
IT1284650B1 (it) * | 1996-05-24 | 1998-05-21 | Sigma Tau Ind Farmaceuti | Farmaco a base di un derivato della carnitina per il trattamento della demenza di alzheimer in pazienti ad insorgenza precoce della patologia |
US6323237B1 (en) | 1997-03-17 | 2001-11-27 | Btg International Limited | Therapeutic compositions |
AU749638B2 (en) * | 1997-03-17 | 2002-06-27 | Btg International Limited | Therapeutic compositions |
US20090253781A1 (en) * | 2002-05-24 | 2009-10-08 | Btg International Limited | Therapeutic compositions |
US6316038B1 (en) | 1997-03-17 | 2001-11-13 | Btg International Limited | Therapeutic compositions |
IT1291127B1 (it) * | 1997-04-01 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica |
US5889055A (en) * | 1997-04-04 | 1999-03-30 | Howard; James R. | L-carnitine and acetyl-L-carnitine combined for prevention and treatment of syndromes related to diseases of energy metabolism |
US5869528A (en) * | 1997-07-22 | 1999-02-09 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Therapeutical method for the treatment of attention-deficit/hyperactive disorders |
IT1299195B1 (it) * | 1998-06-25 | 2000-02-29 | Sigma Tau Healthscience Spa | Composizione ad attivita' neuroprotettiva per la prevenzione ed il trattamento delle alterazioni nervose e comportamentali legate a stati |
IT1302365B1 (it) * | 1998-10-09 | 2000-09-05 | Sigma Tau Healthscience Spa | Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali |
US6335361B1 (en) * | 1999-11-03 | 2002-01-01 | Juvenon Inc. | Method of treating benign forgetfulness |
US20080009467A1 (en) * | 2000-05-01 | 2008-01-10 | Accera, Inc. | Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism |
DE60138019D1 (de) * | 2000-05-01 | 2009-04-30 | Accera Inc | Verwendung von triglyceriden mit mittellangen ketten zur behandlung und vorbeugung der alzheimerschen erkrankung |
US6835750B1 (en) | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
US20070179197A1 (en) * | 2000-05-01 | 2007-08-02 | Accera, Inc. | Compositions and methods for improving or preserving brain function |
CA2448246A1 (fr) * | 2001-05-29 | 2002-12-05 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A | Utilisation d'un alkanoyl l-carnitine pour la preparation d'une medication destinee au traitement de l'anhedonie |
US20100010336A1 (en) * | 2002-02-07 | 2010-01-14 | Pettegrew Jay W | Method and system for diagnosis of neuropsychiatric disorders including attention deficit hyperactivity disorder (adhd), autism, and schizophrenia |
KR20040083471A (ko) * | 2002-02-07 | 2004-10-02 | 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. | 노인성 우울증의 치료에서 카르니틴의 용도 |
US20050272812A1 (en) * | 2002-02-07 | 2005-12-08 | Pettegrew Jay W | Methor for use of acetyl-L-carnitine (ALCAR) for treatment of depressive disorders in humans |
US8894973B2 (en) * | 2002-02-07 | 2014-11-25 | Jay W. Pettegrew | Method and system for differential diagnosis of chronic schizophrenia and chronic alcoholism |
US7407778B2 (en) * | 2002-02-07 | 2008-08-05 | Pettegrew Jay W | Compounds, compositions and methods for treating neuropsychiatric disorders |
US7700074B2 (en) * | 2002-02-07 | 2010-04-20 | Pettegrew Jay W | Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism |
US20060257842A1 (en) * | 2003-05-29 | 2006-11-16 | Pettegrew Jay W | Cryopreservation media and molecules |
EP1641806B1 (fr) * | 2003-05-29 | 2009-07-29 | Jay W. Pettegrew | Composes, compositions et procedes d'imagerie medicale permettant d'obtenir des image de troubles neuropsychiatriques |
US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
GB0420856D0 (en) * | 2004-09-20 | 2004-10-20 | Ketocytonyx Inc | Cns modulators |
WO2006020137A2 (fr) | 2004-07-16 | 2006-02-23 | Ketocytonyx Inc. | Composes oligomere |
EP1778615A4 (fr) * | 2004-07-20 | 2010-01-06 | Btg Int Ltd | Composes cetoniques oligomeres |
EP1778212A4 (fr) * | 2004-07-23 | 2010-12-08 | Btg Int Ltd | Saccharides cetogenes |
EP1793813A4 (fr) * | 2004-09-21 | 2011-05-18 | Btg Int Ltd | Traitement du trouble d'hyperactivite avec deficit de l'attention (thada) |
ES2574557T3 (es) * | 2004-09-21 | 2016-06-20 | Btg International Limited | Miméticos dopaminérgicos |
US20060252775A1 (en) * | 2005-05-03 | 2006-11-09 | Henderson Samuel T | Methods for reducing levels of disease associated proteins |
WO2007001883A2 (fr) * | 2005-06-20 | 2007-01-04 | Accera, Inc. | Procédé visant à réduire les dommages oxydatifset à améliorer l’efficacité des mitochondries |
EP2001293B9 (fr) * | 2006-04-03 | 2019-04-17 | Accera, Inc. | Utilisation de composés cétogènes pour le traitement des troubles cognitifs liés à l'âge |
EP2650381B1 (fr) | 2007-07-31 | 2016-09-21 | Accera, Inc. | Utilisation d'essais génomiques et composés cétogéniques pour le traitement d'une fonction cognitive réduite |
CN102105071A (zh) * | 2008-07-03 | 2011-06-22 | 艾克塞拉公司 | 用于治疗神经性障碍的乙酰乙酸的单甘油酯及其衍生物 |
SG10201503032UA (en) * | 2010-06-16 | 2015-06-29 | Sigma Tau Ind Farmaceuti | Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue |
AU2021272292A1 (en) | 2020-05-15 | 2023-02-02 | Alfasigma S.P.A. | Composition comprising methylfolate |
IT202100020729A1 (it) | 2021-08-02 | 2023-02-02 | Univ Degli Studi Di Napoli Federico Ii | Preparazione combinata per il trattamento della malattia di Pompe |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE700864A (fr) * | 1967-07-03 | 1967-12-18 | ||
GB1256162A (en) * | 1968-08-16 | 1971-12-08 | Braun Fa B | Improvements in and relating to liquid products for intravenous administration |
US3810994A (en) * | 1972-06-01 | 1974-05-14 | Ethyl Corp | Method and composition for treating obesity |
JPS531812B2 (fr) * | 1972-12-07 | 1978-01-23 | ||
AU518617B2 (en) * | 1977-04-29 | 1981-10-08 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Therapeutic application of acetyl-d, 1-carnitine |
IT1143611B (it) * | 1977-11-03 | 1986-10-22 | Sigma Tau Ind Farmaceuti | Applicazione della acetil-carnitina nella terapia delle affezioni cardiache di/tipo anossico,ischemico,cardiotossico e nelle sindromi aritmiche |
FR2414914A1 (fr) * | 1978-01-18 | 1979-08-17 | Sigma Tau Ind Farmaceuti | Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine |
IT1156741B (it) * | 1978-05-15 | 1987-02-04 | Sigma Tau Ind Farmaceuti | Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi |
-
1980
- 1980-02-05 US US06/119,075 patent/US4346107A/en not_active Expired - Lifetime
- 1980-02-06 AU AU55267/80A patent/AU535518B2/en not_active Expired
- 1980-02-07 NL NL8000768A patent/NL8000768A/nl not_active Application Discontinuation
- 1980-02-08 CH CH102880A patent/CH641673A5/it not_active IP Right Cessation
- 1980-02-12 GB GB8004602A patent/GB2046593A/en not_active Withdrawn
- 1980-02-12 FR FR8003015A patent/FR2448348A1/fr active Pending
- 1980-02-12 BE BE0/199368A patent/BE881680A/fr not_active IP Right Cessation
- 1980-02-12 DE DE19803005208 patent/DE3005208A1/de active Granted
Also Published As
Publication number | Publication date |
---|---|
CH641673A5 (it) | 1984-03-15 |
GB2046593A (en) | 1980-11-19 |
NL8000768A (nl) | 1980-08-14 |
FR2448348A1 (fr) | 1980-09-05 |
AU5526780A (en) | 1980-08-21 |
US4346107A (en) | 1982-08-24 |
DE3005208C2 (fr) | 1989-12-28 |
AU535518B2 (en) | 1984-03-29 |
DE3005208A1 (de) | 1980-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE881680A (fr) | Composition pharmaceutique a base d'acylcarnitine pour le traitement d'un metabolisme cerebral altere et methode utilisee a cet effet | |
BE881681A (fr) | Composition pharmaceutique a base d'acylcarnitine pour le traitement des maladies vasculaires peripheriques, et methode utilisee a cet effet | |
BE893559A (fr) | Traitement d'affections arthritiques | |
MA18939A1 (fr) | Procede de preparation d'un agent pour le traitement de theilerioses | |
FR2509613B1 (fr) | Medicament a base d'insuline pour le traitement du diabete sucre | |
FR2577111B1 (fr) | Machine pour le traitement des poireaux | |
FR2508034B1 (fr) | Procede de preparation d'amides acryliques et methacryliques | |
FR2333515A1 (fr) | Compositions pharmaceutiques pour le traitement des troubles du metabolisme du calcium | |
FR2499408B1 (fr) | Composition pharmaceutique pour le traitement de l'osteopathie, a base d'acide 6-amino-1-hydroxyhexane-1,1-diphosphonique | |
BE881208A (fr) | Composition pharmaceutique pour le traitement de psoriasis et methode d'utilisation de celle-ci | |
FR2575073B1 (fr) | Appareil pour le traitement du pied d'athlete | |
FR2488135B1 (fr) | Composition pharmaceutique a base de propylene-glycol et d'acetaminophene | |
FR2529081B1 (fr) | Composition therapeutique a base d'acide 5-hydroxydecanoique ou d'un de ses derives pour le traitement des maladies cardiovasculaires | |
BE885368A (fr) | Compositions pharmaceutiques pour le traitement des complications associees au diabete | |
GB2105992B (en) | Pharmaceutical composition for treatment of cardio-vascular diseases | |
FR2614791B1 (fr) | Association medicamenteuse a base de plantes et oligoelements pour le traitement de rhumatismes et etats inflammatoires | |
FR2519655B1 (fr) | Composition de chromate et procede de traitement d'alliages de zinc-nickel | |
DE3362340D1 (en) | A pharmaceutical composition and the use thereof for the treatment of inflammation | |
RO88351A3 (fr) | Composition pour le traitement des affections gastroduodenales | |
PT78208A (en) | Process for the preparation of analgesic pharmaceutical compositions containing n-(4-hydroxyphenyl)-acetamide and 5-chloro-(2-imidazolin-2-yl-amino)-2,1,3-benzothiazole | |
DE3667109D1 (en) | Liquid for the treatment of a photoresist composition, and process therefor | |
BE894228A (fr) | Composition pharmaceutique pour le traitement de l'atherosclerose | |
FR2517542B1 (fr) | Medicament pour l'amelioration du metabolisme lipidique | |
BE851702A (fr) | Procede et compositions pour le traitement d'etats pathologiques du cerveau | |
FR2562798B1 (fr) | Agent pharmaceutique pour le traitement du psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE20 | Patent expired |
Owner name: CAVAZZA CLAUDIO Effective date: 20000212 |